Bladder Cancer Research: Multiplexed autoantibody profiling | Dana-Farber Cancer Institute

0 Views
administrator
administrator
07/08/23

Dana-Farber's Guru Sonpavde, MD, highlights research from ASCO GU22: Multiplexed autoantibody profiling of patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors or platinum-based chemotherapy. http://ms.spr.ly/6053wztS1
Video published 2/15/22

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next